Hospital Corporation of China posts strong net profit, revenue up in first half

Hospital Corporation of China Limited reported a total revenue of 743,044 thousand yuan for the six months ended 30 June 2025, a 3.3% increase from 719,503 thousand yuan in the corresponding period of the previous year. This growth was primarily driven by an increase in general hospital services revenue from individual patients. Despite a decrease in adjusted gross profit by 4.2% to 154,981 thousand yuan and a 19.2% decrease in adjusted net profit to 70,584 thousand yuan, the Group recorded a net profit of 168,620 thousand yuan, a substantial improvement from 23,568 thousand yuan in the prior year. Basic earnings per share were 1.13 yuan, reversing a loss of 0.15 yuan in 2024.

The Group's financial position strengthened, with total equity increasing to 727,292 thousand yuan as of 30 June 2025, up from 576,623 thousand yuan at 31 December 2024. Current assets stood at 1,019,725 thousand yuan, while current liabilities decreased significantly to 668,445 thousand yuan, primarily due to a reduction in convertible bonds. The current ratio improved to approximately 1.53 from 0.61. The Company also successfully extended the maturity dates of its convertible bonds to September 2027, deferring significant cash outflows. No interim dividend was recommended for the period.